TOKYO and WOODCLIFF LAKE, N.J., Dec. 27 - Eisai Co., Ltd.(Headquarters: Tokyo, President and CEO: Haruo Naito) and Eisai Inc.(Headquarters: New Jersey, Chairman and CEO: Hajime Shimizu) ...
Princeton, New Jersey; June 1, 2011 - Sandoz today announced the US Food and Drug Administration (FDA) approval and US launch of donepezil hydrochloride (HCL) film-coated tablets and donepezil HCL ...
Japanese drugmaker Eisai has filed a lawsuit to defend its recently launched orally-disintegrating tablet formulation of Alzheimer's disease drug Aricept from generic competition in the USA. Japanese ...
DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/wxk8pg/key_findings_from) has announced the addition of Decision Resources ...
Jan. 3, 2006 — The Chinese Food and Drug Administration has approved qiyao capsules for adjunctive use in the treatment of type 2 diabetes; completion of the mutual recognition procedure has allowed ...
December 17, 2009 — The US Food and Drug Administration (FDA) has approved the first generic versions of donepezil HCl orally disintegrating tablets (generic, Mutual Pharmaceutical; brand name, ...
GENEVA, SWITZERLAND (4 APRIL 2002) - Results from the first head-to-head study comparing ARICEPT® (donepezil HCl tablets) and Reminyl® (galantamine HBr tablets) demonstrated significantly greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results